SDS Pharmaceuticals Private Limited
About SDS Pharmaceuticals Private Limited
Data last updated:
SDS Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2014PTC264882.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anil Kumar Gupta and Krishan Mohan Sharan.
Its last annual general meeting (AGM) was held on 20 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 2/388 Janakpuri, New Delhi, Delhi, India – 110058.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
SDS Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC – 2/388 Janakpuri, New Delhi, Delhi, India – 110058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of SDS Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of SDS Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of SDS Pharmaceuticals Private Limited, buy the company report.
Financials of SDS Pharmaceuticals Private Limited
FY 2025 filings availableSDS Pharmaceuticals Private Limited reported revenue of ₹6,200 (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over three years, including 3% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SDS Pharmaceuticals Private Limited, buy the company report.
Board of directors of SDS Pharmaceuticals Private Limited
SDS Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Gupta Also directs: Bfsi Technologies Private Limited | Director | 13 Feb 2014 | 12 Years 8 Months | Current |
| Krishan Mohan Sharan Also directs: Gold Space Logistics LLP, Sudha Service Station LLP, Shrimohan Buildtech LLP and 5 more | Director | 13 Feb 2014 | 12 Years 8 Months | Current |
| Anil Mohan Sharan | Director | 13 Feb 2014 | 12 Years 8 Months | Current |
Auditor
SDS Pharmaceuticals Private Limited is audited by ARPIT AGGARWAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARPIT AGGARWAL & ASSOCIATES | FY 2021 | 026928N |
Shareholding
The shareholding of SDS Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of SDS Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving SDS Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SDS Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for SDS Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
SDS Pharmaceuticals Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Anil Kumar Gupta was appointed as Director on 13 Feb 2014.
Frequently asked questions
SDS Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 February 2014 (12+ years old) and is registered under CIN U24232DL2014PTC264882.
SDS Pharmaceuticals has 3 current directors:
- Anil Kumar Gupta - Director
- Krishan Mohan Sharan - Director
- Anil Mohan Sharan - Director
The latest financial statements of SDS Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of SDS Pharmaceuticals is U24232DL2014PTC264882. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SDS Pharmaceuticals was incorporated on 13 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Anil Kumar Gupta was appointed as Director on 13 Feb 2014. Anil Mohan Sharan was appointed as Director on 13 Feb 2014. Krishan Mohan Sharan was appointed as Director on 13 Feb 2014.
The registered office of SDS Pharmaceuticals is at C – 2388 Janakpuri, New Delhi, Delhi, India – 110058.
SDS Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of SDS Pharmaceuticals is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.
SDS Pharmaceuticals can be reached at its registered office: C – 2388 Janakpuri, New Delhi, Delhi, India – 110058.